Posts

Image

Taking on the access hurdles for orphan drugs: preparing for EU HTA

Image

Disrupting HTA and HEOR: the role of AI

Image

Finding new treatments for ALS patients: a look at the late-stage pipeline

Image

EU HTA is now live: what do we do now?

Image

Turning Setbacks into Strategies: Lessons from RELYVIRO’s journey in ALS

Image

Medicamentos modificadores de la enfermedad para el Parkinson: ¿una nueva ola en el horizonte?

Image

Disease-Modifying Drugs for Parkinson's Disease: A New Wave on the Horizon?

Image

Changes in Market Access in Europe and Implications for Clinical Development Planning: Joint Clinical Assessments